drugset / Trial / NCT01043913

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

NCT01043913 ↗

Phase 2 Completed 60 enrolled Faculdade de Medicina do ABC
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators hypothesize that Guaraná, a native plant from the Amazon, might improve chemotherapy-induced fatigue in breast cancer patients undergoing treatment. In order to assess this, the investigators randomized patients to either guaraná extract or to placebo, switching the assigned treatment mid-term through the cycles of Chemotherapy.

Timeline

Start
2008-02
Primary completion
2009-09
Completion
2009-12

Outcome

Missed primary endpoint

paper We were unable to show any statistically significant differences between the guaraná and the placebo-treated group with any of the measured scores. PMID 19388866 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaraná Traditional medicine (herbal / TCM) 50 mg Oral

Indications